8,156
Views
40
CrossRef citations to date
0
Altmetric
Reviews

Importance of brucellosis control programs of livestock on the improvement of one health

ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 137-151 | Received 25 Feb 2020, Accepted 20 Feb 2021, Published online: 08 Mar 2021

Abstract

Brucellosis not only represents an important health restraint on livestock but also causes high economic losses in many developing countries worldwide. Despite considerable efforts made for the control of brucellosis, the disease is still spreading in many regions (such as the Middle East) where it represents one of the most important health hazards impacting both animals and humans. The present review aims to investigate the efficacy of veterinary control programs regarding brucellosis, with a special focus on current prevention, control, and eradication approaches. The reasons for unsuccessful control programs such as the absence of highly effective vaccines and non-certified bulls are also debated, to understand why the prevalence of brucellosis in livestock is not decreasing in many areas despite considerable efforts taken to date. The importance of governmental and regional investment in brucellosis control remains one of the main limiting factors owing to the limited budget allocated to tackle this disease. In this context, one health concept has generated novel comprehensive approaches with multiple economic implications across the livestock industry and public health. However, the implementation of such global preventive strategies appears to be a key issue for many endemic and low-income countries. According to the collected data, epidemiological contexts including management and trade systems along with well-defined agro-ecological zones should be evaluated in brucellosis endemic countries to improve milk production and to enhance the sustainability of the livestock sector at both national and regional levels.

1. Introduction

Brucellosis is a contagious and widespread zoonotic disease of domestic and wild animals in different regions worldwide (Franc et al. Citation2018). Brucella spp. are non-spore-forming pathogens, non-motile aerobic Gram-negative coccobacilli with small size of 0.6–1.5 μm in length and 0.5–0.7 μm in diameter that categorized in the family of Brucellaceae. The family Brucellaceae comprises the genus Brucella and six further genera, including Ochrobactrum, Daeguia, Crabtreella, Mycoplana, Pseudochrobactrum, and Paenochrobactrum which are phylogenetically members of the order Rhizobiales within the class Alphaproteobacteria (Leclercq et al. Citation2020). Twelve species are currently described in the genus of Brucella that infect different wildlife and domestic animal species (Whatmore et al. Citation2016). Among these, six Brucella species have been categorized according to their pathogenicity and preferred hosts as Brucella abortus (cattle), B. melitensis (goats and sheep), B. ovis (rams), B. canis (dogs), B. suis (pigs), and B. neotomae (Common voles, desert wood rat). The most important pathogenic species in man are known as B. melitensis, B. suis, and B. abortus (Omer et al. Citation2000; Lindahl et al. Citation2014; Wareth et al. Citation2014; Kaynak-Onurdag et al. Citation2016; Whatmore et al. Citation2016). Recently, two new Brucella spp., B. ceti (dolphins, porpoises and whales), and B. pinnipedialis (walruses and seals) have been reported from marine mammal hosts according to their pathogenicity and preferred hosts (Cvetnić et al. Citation2016; Ness et al. Citation2017). Furthermore, Brucella species such as B. inopinata have been isolated from humans (Scholz et al. Citation2010; Olsen and Palmer Citation2014) and B. papionis sp. nov. along with new Brucella-like coccoid bacteria also were reported from baboons (Papio spp.) (Whatmore et al. Citation2014). Apart from well-known endemic regions, brucellosis remains a neglected disease in many areas worldwide which can lead to serious health and economic concern for the livestock populations by affecting animals such as cattle, buffalo, camel, sheep and goat (Sulima and Venkataraman Citation2010; Santos et al. Citation2013; Mableson et al. Citation2014; Bamaiyi Citation2015; Singh et al. Citation2015). Economic losses of brucellosis for the livestock industry and small-scale livestock holders are usually due to infertility in both sexes and late term abortion (Sulima and Venkataraman Citation2010; Angara et al. Citation2016; Awah-Ndukum et al. Citation2018; Deka et al. Citation2018; Franc et al. Citation2018), decreased milk yield (Herrera et al. Citation2008; Mellado et al. Citation2014), decreased productivity, loss in market value of animals, lost draught power, missed reproductive cycles, birth of weak offspring with low birth weight, and increased veterinary costs in farms (Blasco and Molina-Flores Citation2011; Dadar et al. Citation2020a). In the cows, the disease leads to an abortion once in their lifetime and the infection is asymptomatic in non-pregnant animals which may remain infected their entire life (Godfroid et al. Citation2010). Moreover, it has been reported that the annual economic losses and prevalence of brucellosis are variable in different countries and Brucella vaccines alone could not eradicate brucellosis, particularly in regions showing high levels of Brucella infection (Seleem et al. Citation2010; Awah-Ndukum et al. Citation2018).

Therefore, vaccination combined with proper measures of husbandry is more likely to achieve successful prevention and control of Brucella infections. However, the complexity of brucellosis control in different endemic countries may offset the preventive effects of applicable long-term intervention approaches on livestock, thereby causing significant economic losses for veterinary instances (Singh et al. Citation2015; Deka et al. Citation2018). Such losses are not confined to the livestock production (reduced milk, delayed conception and abortion) (Bamaiyi Citation2015; Avila-Granados et al. Citation2019; Machavarapu et al. Citation2019), rather extending over the global public health system (cost of treatment and productivity loss) (Dadar et al. Citation2019b).

This review focuses on the importance of veterinary control programs regarding brucellosis, with a special focus on the current prevention, control, and eradication approaches.

2. Pathogenesis of Brucella spp. and involved immune mechanisms

Brucella spp. could proliferate within the macrophages and escape from host defense mechanisms and can infect human host by contact with mucosa or inhalation, puncture wounds such as needle sticks as well as ingestion (Hull and Schumaker Citation2018). Brucella needs four steps to infect the host, namely containing adherence, invasion, establishment, and dissemination within the host (Christopher et al. Citation2010). The pathogen can survive in the macrophages and then multiply and control the fusion of phagosome–lysososme complex (Gopalakrishnan et al. Citation2016). After that, the accumulated bacteria are circulated to other cells of host (Ko and Splitter Citation2003). Moreover, it has been reported that there are five virulence factors for Brucella spp. which are necessary for infection and intracellular survival, including cyclic β-glucan (Martirosyan et al. Citation2012), virB T4SS (de Jong et al. Citation2013), pathogen-associated molecular patterns (PAMPs), two component sensory and regulatory system BvrS/BvrR (Martín-Martín et al. Citation2012), and Brucella LPS (BrLPS) (Lapaque et al. Citation2005). Furthermore, other virulence factors in Brucella spp. are comprised of outer membrane proteins (Omps) (Lim et al. Citation2012; Vizcaíno and Cloeckaert Citation2012), BacA (Martín-Martín et al. Citation2012), SagA (Del Giudice et al. Citation2013), BmaC (Posadas et al. Citation2012), BetB (Lee et al. Citation2014), BtaE (Ruiz-Ranwez et al. Citation2013) and MucR (Mirabella et al. Citation2013). Also, a genomic island (GIFeGSH) is associated with pathogenicity of Brucella which has been described in the genome of B. canis (Wahab et al. Citation2017). However, this bacterium does not contain any plasmid associated with the pathogenicity of its genome that make it different from other bacterial species (Bano and Lone Citation2015). Moreover, the genome also lacks the numerous other common virulence genes such as fimbriae, antigenic variation, capsules, cytolysins, exotoxins, resistance forms, plasmids, or lysogenic phages (Detilleux et al. Citation1990; Moreno et al. Citation2002). Several antigenic components of Brucella such as Omp16, Omp19, Omp25, Omp31, SurA, Dnak, trigger factor (TF), ribosomal protein L7L12, bacterioferritin (BFR) P39, and lumazine synthase BLS have been characterized (Bundle et al. Citation1989; Barrionuevo and Giambartolomei Citation2019; Yin et al. Citation2019). Efforts were instead concentrated on surface antigens (described as R in rough strain and A, M in smooth strains) and lipopolysaccharide (LPS) expected to trigger specific antibody response (Mancilla Citation2016; Głowacka et al. Citation2018; Jezi et al. Citation2019). The specific structure of LPS in the Brucella confers resistance to antimicrobial drugs, while inducing a very low endotoxicity. The LPS of Brucella also organizes the virulence factor and regulates the intracellular replication as well as its survival in the host (Christopher et al. Citation2010; Atluri et al. Citation2011). LPS comprised of lipid A, O-antigen and oligosaccharide core in Gram-negative bacteria (Głowacka et al. Citation2018). It has also been reported that antigen M predominates in B. melitensis, whereas antigen A is predominant in B. suis and B. abortus (Casabuono et al. Citation2017; Kumar et al. Citation2019). Moreover, lipid A containing unique fatty acids, excepting ß-hydroxymyristic acid and two types of aminoglycose, are the main components in the LPS of smooth phase strains (S-LPS). The core region of Brucella S-LPS is composed of glucose, mannose, and quinovosamine with an O chain that contains a homopolymer of nearly 100 residues of 4-formamido-4,6-dideoxymannose (Fontana et al. Citation2016; Smith Citation2018). Several studies using murine models revealed that the main host response to Brucella spp. could be attributed to T helper 1 (Th1), along with production of gamma interferon (IFN-γ) by natural killer (NK) cells and T cells (Copin et al. Citation2007; Rolán and Tsolis Citation2008). Moreover, both CD4 and CD8 T cells improve the limitation of Brucella infection, that may reveal their function as IFN-γ sources (Araya et al. Citation1989). Furthermore, B. abortus could stimulate the release of anti-inflammatory cytokine interleukin-10 (IL-10) along with an early Th1 response (Svetić et al. Citation1993; Xavier et al. Citation2013). However, the macrophages, B cells, and CD4 T cells could produce the IL-10 which can restrict the antagonizing role of IFN-γ, as well as the microbicidal activity of macrophages against Brucella (Fernandes and Baldwin Citation1995).

3. Economic losses due to brucellosis

Economic losses associated with brucellosis in livestock have been reported in different countries (Islam et al. Citation1983; McDermott et al. Citation2013; Santos et al. Citation2013; Singh et al. Citation2015). Although estimates of the costs associated with brucellosis infections remain limited to specific countries, all data suggest that worldwide economic losses due to brucellosis are extensive regarding both livestock health, production and public health (cost of treatment and productivity loss in man) (Sriranganathan et al. Citation2009). For example, epidemiological surveys conducted in India reported a median US $3.4 billion estimated economic loss due to livestock brucellosis (Mantur and Amarnath Citation2008; Singh et al. Citation2015, Citation2018; Machavarapu et al. Citation2019). In another official report, the annual economical losses due to bovine brucellosis have been reported at approximately $600 million in Latin America (Sriranganathan et al. Citation2009). A 20–30% decrease in milk production has been estimated in brucellosis-affected farms (Herrera et al. Citation2008; Havelaar et al. Citation2019). A few countries provide accurate reports regarding their losses due to brucellosis such as Argentina, with an annual loss reaching US $60 million (Samartino Citation2002), India with a median loss of US $3.4 billion (Singh et al. Citation2015) for cattle, sheep and goat, Egypt with US $9.8 million (Bamaiyi Citation2015), United States with US $30 million (Bittner Citation2004), Brazil with approximately US $448 million (Santos et al. Citation2013), and Kyrgyzstan about US $10.6 million (Bamaiyi Citation2015). In Nigeria, the annual economic losses caused by brucellosis in small ruminants were US $3.2 million two decades ago (Brisibe et al. Citation1996). However, the brucellosis eradication programs may be very expensive in developing countries (Zhang et al. Citation2018). For example, in the USA the estimated cost of the national brucellosis eradication program was around $3.5 billion between 1934 and 1997 (Sriranganathan et al. Citation2009). Multiple economic implications for livestock industry and public health led to efforts to control brucellosis in endemic and low-income countries through different approaches that will be discussed in the next sections (McDermott et al. Citation2013; Islam et al. Citation2018a).

4. Brucella spp. shedding in milk

The contamination of dairy products by Brucella species showed variable prevalence according to the studied country and geographical area (Dadar et al. Citation2019b). For example, brucellosis prevalence in middle and low income countries is high because of various implicated livestock species, different management systems, and specific national or regional veterinary and medical programs (McDermott et al. Citation2013). It should be noted that different indirect and direct methods, with various sensitivity and specificity have been applied for detection of Brucella species in dairy products, although the bacterial isolation is still recognised as the “gold standard” for brucellosis diagnosis. The prevalence of Brucella spp. in contaminated milk appeared to be of great value for risk evaluation in high risk populations considering the fact that B. melitensis and B. abortus usually infect humans through the consumption of contaminated milk products from cattle, camel, goat or sheep (Franc et al. Citation2018; Dadar et al. Citation2019b, Citation2020a). It has been reported that the incidence rate of Brucella spp. remains high in different middle income countries, including Iran (Moosazadeh et al. Citation2016; Alamian and Dadar Citation2019; Dadar et al. Citation2019a), Nigeria (Bale et al. Citation2003; Salisu et al. Citation2017), India (Aulakh et al. Citation2008; Proch et al. Citation2018), Turkey (Gulbaz and Kamber Citation2016; Kaynak-Onurdag et al. Citation2016), Brazil (Langoni et al. Citation2000; Lemos et al. Citation2018), Pakistan (Ali et al. Citation2013, Citation2014), Egypt (Wareth et al. Citation2014, Citation2017), China (Ning et al. Citation2013), and Bangladesh (Islam et al. Citation2019). Furthermore, Brucella spp. contamination was reported in milk of several animal species such as cattle, water buffalo, sheep, goats and camels. Several risk factors were identified including animal species, age, and pregnancy conditions as well as the occurrence of reproductive disorders. Furthermore, some environmental conditions, including milk storage and hygienic conditions, herd size, study area, and breeding approaches represent other key factors (Omer et al. Citation2000; Ning et al. Citation2013; Ness et al. Citation2017; Deka et al. Citation2018; Proch et al. Citation2018; El-Wahab et al. Citation2019; Dadar et al. Citation2019b). However, the incidence of brucellosis in different hosts and countries is directly associated with eradication and control programs in livestock that should be implemented by national veterinary services such as vaccination and “test and slaughter” policy.

5. Brucellosis control strategies

According to the World Health Organization (WHO), brucellosis is classified as one of the seven neglected zoonotic disease involved in a high portion of poverty in developing countries (Pérez-Sancho et al. Citation2015). In addition, a control program for brucellosis outbreak is valuable in preservation of dairy herd. All or some of the following control programs such as sanitation, test and removal approaches and/or vaccination can be used for brucellosis control programs (Olsen and Stoffregen Citation2005). Furthermore, vaccination of cattle between 4 and 12 months of age as well as cattle over the ages of 12 months is the most economic measure for brucellosis control (Nicoletti Citation1984). However, vaccination alone is not acceptable for the elimination of brucellosis in any host species (Olsen and Stoffregen Citation2005). Currently, RB51 and S19 are the live vaccine strains of B. abortus that more widely applied to control brucellosis in cattle (Beauvais et al. Citation2016; Hou et al. Citation2019). Moreover, the most effective strategy for eradication and control of brucellosis in young and adult small ruminant animals is with the Brucella melitensis REV-1 vaccine. This approach is evaluated as the most efficient in type of extensive or nomadic husbandry and in cases that brucellosis prevalence is high among small ruminants (Minas et al. Citation2004; Godfroid et al. Citation2013). Vaccine coverage and vaccine efficacy is critical to prevent Brucella infections in small ruminants and appear to be the key factor for the success of B. melitensis control programs (Beauvais et al. Citation2016). The planned control program need to evaluate numerous factors such as understanding of regional and local variations in animal epidemiological patterns of the brucellosis, cross-sectoral brucellosis epidemiological coordination and surveillance, husbandry practices, the level of infrastructure support, community awareness, and social customs (Seimenis et al. Citation2019). In countries showing a low prevalence of bovine brucellosis, a test-and-slaughter strategy can be applied in order to control the diseases in dairy farms (Tesfaye et al. Citation2011). Other preventive strategies such as the certification of brucellosis free herds and the vaccination of female bovines, have also been reported as effective approaches for brucellosis control (Renukaradhya et al. Citation2002; Herrera et al. Citation2008; Blasco and Molina-Flores Citation2011; Avila-Granados et al. Citation2019). In this respect, strict national surveillance programs are necessary to recognize infected herds, and would allow any subsequent corrective and preventive measures to be taken in (Renukaradhya et al. Citation2002; Rivera et al. Citation2002). Finally, an effective brucellosis control of animal needs different approaches such as animal surveillance by serological tests to determine infected animals, the control of brucellosis transmission to non-infected animal herds as well as the elimination of the animal carriers of the bacteria such as dog, cat and mice in the herd to eradicate the sources of infection (Gwida et al. Citation2010; Kiros et al. Citation2016). The cooperation and support of farmers are crucial for implementing long-term eradication and control programmes. Therefore, veterinary organizations should increase farmers' awareness regarding preventive strategies and transmission routes through continuous education and training programs. The accessibility to necessary resources needed for prevention and appropriate veterinary services are also important requirements.

6. Risk factors of Brucella spp. infection in dairy cattle farms

It was shown that the identification of brucellosis risk factors in livestock is of overwhelming importance to prevent the spread and persistence of this disease in different regions (Ning et al. Citation2013; Moosazadeh et al. Citation2016). A cross-sectional study including 99 dairy cattle herds (1294 female cattle sampled) was performed to define main risk factors for brucellosis infection in herds located in the suburbs of Asmara, Eritrea using a multiple betabinomial regression model (Omer et al. Citation2000). A variety of potential risk factors have been identified such as farm size, herd size, stocking density, type of herd, methods of disposal of manure, purchase source and frequency and the use of calving pens. In addition, mixed farming and the presence of horses or other animals (dog, sheep, cat, poultry, monkey) in the farm as well the type of service used for breeding (natural or artificial insemination), type of labor used (family or hired members) and the use of permanent housing for cows were also considered in this study (Omer et al. Citation2000). The authors concluded that stock density and herd type were independently related to the prevalence of Brucella spp, while herds with mixed-breeds were more likely to be seropositive in comparison with the herds subjected to exotic breeds (Omer et al. Citation2000). Another study also confirmed that mixed farming and larger herd size were the main risk factors elevating cattle Brucella infections (Al-Majali et al. Citation2009). It was shown in a study performed in different areas of Zimbabwe that geographical location, Brucella seropositivity, large herd size and frequent cattle purchase are major risk factors influencing the abortion incidence in small household herds (Matope et al. Citation2011a). Moreover, a total of 1,440 cattle from 203 herds were evalued in order to define risk factors associated with the presence of elevated levels of Brucella antibodies and showed that the application of stamping out program, promoting the use self-contained units and testing programs in livestock before movement are important to decrease the risks related to Brucella infections in dairy farms (Matope et al. Citation2011b). Pathak and his colleagues (2016) also reported that inadequate floor space and the lack of knowledge about brucellosis were important risk factors for bovine brucellosis transmission (Pathak et al. Citation2016). Poor implementation of critical control programs for animal brucellosis such as reporting disease to the veterinary services, testing of animals and restricting movement of infected cattle also has been reported in Cameroon as the associated risk factors of brucellosis (Awah-Ndukum et al. Citation2018). Furthermore, a good health system and active involvement of the populations at risk are also lacking in this region. Recent epidemiological studies showed that the sex and breed of dairy cattle, abortion history, abortion period along with farm location (farms located on steeper terrains) and farmer knowledge about the occupational risk of brucellosis had important influences on the brucellosis incidence among dairy cattle population (Halliday et al. Citation2015; Akinseye et al. Citation2016; Geresu et al. Citation2016; Carbonero et al. Citation2018). In addition, a cross sectional study around Alage district of Ethiopia revealed that the seroprevalence of bovine brucellosis and associated risk factors are significantly linked to the sex, age, reproductive status, calving interval, and number of service per conception (Asgedom et al. Citation2016). The survey of Brucella risk factors among 68 dairy farms with no positive cases of bovine brucellosis and 13 dairy farms with positive results for the Brucella Rose Bengal test (RBT) was carried out. It was shown that having a history of reactor cattle to brucellosis and sharing of water sources for cattle with and within outside farms are important risk factors for Brucella infection (Tukana and Gummow Citation2017).

Also, another study revealed that farmers did not hesitate to sell cows that experienced abortion, thereby representing a significant risk factor and neglected culprit in the spread of the disease (Asakura et al. Citation2018). The abortion of these cows may occur because of significance hazards; therefore, the analysis of the behaviour and perception of cattle keepers would provide important data in potential brucellosis control programs. The evaluation of brucellosis risk factors in peri-urban dairy farms of different parts of Indian cities also confirm that seroprevalence is significantly affected by the husbandry system. Increased risk could be related to intensive farming practices, often using artificial insemination methods which represent important risk factors (Lindahl et al. Citation2019). However, the surveillance of bovine and caprine brucellosis in most endemic countries in Africa is commonly poor. Low or poor income communities and lack of public awareness also have been mostly related to the understimation of brucellosis (Halliday et al. Citation2015).

7. Detection methods and identification of Brucella spp. in the milk of infected cattle, sheep, goats and camels

The detection of Brucella spp. in the milk and dairy herds is of overwhelming public health and economic importance (Junaidu et al. Citation2011; Bano and Lone Citation2015; Dadar et al. Citation2020a). Although, specialized cells of the mammary gland could synthesize milk as a sterile fluid when secreted into the alveoli of the udder (Reta et al. Citation2016), Brucella contaminations originate from within or outside the udder (Ragan and Animal and Plant Health Inspection Service Citation2002). An interesting study revealed the effective role of macrophages in transporting B. abortus from the systemic circulation into the mammary glands and milk, the intracellular multiplication in alveoli and ducts, and the transport of the organism from the infected gland to supramammary lymph nodes (Meador et al. Citation1989). Another possible way of milk contamination is microorganisms present in the bulk tank, on the surfaces of the milking equipment, within the farm environment as well as the interior of teats (Jayarao et al. Citation2004). Diagnostic methods of brucellosis are mainly according to serology tests, including SAT, RBT, CFT and iELISA as a corner stone approach, with the greatest immunological responses in different hosts for the LPS smooth chains (Nielsen Citation2002; Chisi et al. Citation2017). Serological tests are simple, inexpensive and could be rapid, although exposure to cross reacting microorganisms are susceptible to false positive reactions (Nielsen Citation2002; Weiner et al. Citation2010). The false positive reactions are known as the main diagnostic problem due to the similarity of the O-antigenic side chain of LPS of Brucella with other organisms such as Escherichia coli O:157, Vibrio cholerae, Francisella tularensis and Yersinia enterocolitica O:9. Although, serological tests such as RBT, SAT, and 2ME are often used for the first screening of brucellosis in livestock, it is now highly recommended to add complementary non-agglutination tests such as ELISA and PCR-based methods to confirm the results, which are quite more expensive. To detect Brucella spp. contaminations, bacterial isolation by culture is considered as the “gold standard” allowing the biotyping of the isolates (Akhtar et al. Citation2010; Dadar et al. Citation2019b). However, the culture of Brucella spp. needs optimal culture media conditions as well as biosafety conditions and can be challenging. Therefore, the detection of Brucella antibodies in milk products using Brucella antigens could be performed by Milk Ring Test (MRT) and immunological methods such as indirect Enzyme Linked Immunosorbent Assay (i-ELISA), that represent the conventional and most available approaches to indirectly confirm the contamination of milk with Brucella spp. (Altun et al. Citation2016; Dadar et al. Citation2020a). A total of 185 raw milk samples, collected from factories and dairy farms in Southwestern Uganda, were tested for Brucella antibodies by the i-ELISA and MRT. It revealed an equal prevalence of 27% by the two tests (Kamwine et al. Citation2017). However, it has been shown that serological results require more confirmation by culture and molecular approaches since presence of antibodies may not firmly indicate brucellosis infection (Karthik et al. Citation2014; Kamwine et al. Citation2017; Ali Hussein et al. Citation2019). PCR-based molecular techniques such as real-time PCR, PCR restriction fragment length polymorphism (RFLP) and Southern blot, Pulse-field gel electrophoresis have also proven high sensitivity in the differentiation and detection of the Brucella DNA (Keid et al. Citation2007; Brucellosis Citation2019; Kolo et al. Citation2019). The first species-specific multiplex PCR assay, named AMOS-PCR, for the differentiation of Brucella was designed according to the polymorphism arising from species-specific localisation of the insertion sequence IS711 in the Brucella chromosome (Bricker and Halling Citation1995). For Brucella identification, further different genes were targeted such as bcsp31(Bounaadja et al. Citation2009), 16S-23S rDNA Interspacer (Keid et al. Citation2007), recA gene (Scholz et al. Citation2008), and RNA Polymerase Beta Subunit (rpoB) (Bazrgari et al. Citation2020) also have been used. Another multiplex PCR assay (Bruce-ladder) also has been described for simple and rapid one-step Brucella identification and differentiation of most Brucella species and the vaccine strains B.melitensis Rev.1, B.abortus strain 19 (S19), and B.abortus RB51(López-Goñi et al. Citation2008). Moreover, real-time quantitative PCR (qPCR) appeared to be highly applicable to the analysis of the occurrence of Brucella contamination in milk, even allowing the discrimination of vaccination strains from virulent strains (Wareth et al. Citation2015; Altun et al. Citation2016; Kaynak-Onurdag et al. Citation2016).

A study performed on 250 samples of unpasteurized buffalo and cattle milk showed that iELISA and real-time PCR (RT-PCR) could effectively detect Brucella antibodies and Brucella-specific DNA, respectively (Wareth et al. Citation2014). The results of this study pointed to the fact that the shedding of Brucella spp. in milk and consumption of non-pasteurized dairy products pose an increasing risk to human consumers. Furthermore, it has been reported that the developed loop mediated isothermal amplification (LAMP) is a rapid and specific diagnostic tool for early and direct identification of Brucella in clinical specimens (Patra et al. Citation2019). In addition, several methods for the optimization of DNA extraction from milk to improve subsequent PCR analysis have been set up leading to the reliable detection of Brucella spp. in milk of infected animals (Leal-Klevezas et al. Citation1995; Ali et al. Citation2014; Gulbaz and Kamber Citation2016; Kaynak-Onurdag et al. Citation2016; Alamian and Dadar Citation2019). The sensitivity and specificity of the PCR were higher when compared to the culture method, allowing the detection of lower concentrations of Brucella organisms in milk (Nimri Citation2003; Amoroso et al. Citation2011; Ning et al. Citation2012). This sensitive and rapid approach has been used for the detection and differentiation of Brucella spp. in camels milk (Sprague et al. Citation2012; Alamian and Dadar Citation2019), as well as in goat, sheep, and cow milk (Hamdy and Amin Citation2002; Dadar et al. Citation2019a). Furthermore, PCR-based methods save about 3 days in Brucella detection compared to incubation-based methods (Kaden et al. Citation2018).

8. Brucella-associated public health concern in the milk supply chains

Acute or sub-acute phases of human brucellosis commonly cause an undulant fever with malaise, prostration, anorexia, sweating, and muscle pain (Manchester Citation1942; Shehabi et al. Citation1990). Specific occupations such as of veterinarians, laboratory workers, farmers, butchers, abattoir workers, and meat inspectors are at high risk of Brucella infections. The consumption of contaminated raw milk, cheese and butter could also transmit this disease (Dadar et al. Citation2020a). A significant relationship exists between the availability of economic resources and the status of brucellosis; as recently shown that the GDP per capita has a clear impact on bovine brucellosis incidence (Dadar et al. Citation2019b). The implementation of appropriate control policies and surveillance programs play an effective role in the reduction of the prevalence of human brucellosis (Cárdenas et al. Citation2019). However, Brucella contamination of milk products still represent an important public health issue in several areas of the world as its prevalence remains difficult to estimate (Dadar et al. Citation2019b). For example, informally marketed cattle milk in Uganda is a risk factor for human brucellosis, showing the importance of an information campaign related to the use of raw milk (Hoffman et al. Citation2016). Furthermore, application of strict surveillance and control policies of milk dairy products and milk pasteurization could decrease significantly the brucellosis incidence in humans (Mailles et al. Citation2016). As demonstrated in different studies, the Middle Eastern countries are highly impacted by brucellosis and contaminated milk products were responsible for several outbreaks of brucellosis in man over the last two decades (Seimenis et al. Citation2019). Also, a history of raw milk consumption and/or raw dairy products was reported in 63% of patients suffering from brucellosis in Turkey (Buzgan et al. Citation2010). Other Turkish studies estimated that the consumption of infected milk products is responsible for 62–94% of human brucellosis cases in Turkey (Gür et al. Citation2003; Buzgan et al. Citation2010). The consumption of contaminated raw milk was also responsible for 63% of human brucellosis cases in Oman (El-Amin et al. Citation2001), 69% in Kuwait (Mousa et al. Citation1988) and 57% in Iran (Moosazadeh et al. Citation2016). The decrease of brucellosis prevalence in livestock could be achieved by avoiding small ruminants and cattle mixing, controlling abortion rate, and culling infected animals after testing. This could lead to a significant decline in Brucella contaminations of milk products, thus considerably reducing human infections (Ning et al. Citation2013). A cross-sectional sero-survey in different villages of Punjab has reported that vaccination of household livestock could decrease the incidence of human brucellosis. Additional measures such as appropriate education related to biosecurity around abortions/calving for health-care workers as well as boiling all milk prior to consumption play an important role for the control of Brucella infections (Mangtani et al. Citation2019). Nevertheless, in urban areas with restricted contact of livestock with human populations, and lower density of animals, the appropriate education and control programs about the use of raw milk products as well as systematic pasteurization of milk products result in an effective preventive strategy to decrease the incidence of human brucellosis.

9. The increase of milk production in dairy farm under brucellosis control programs

Brucellosis is a reproductive zoonotic disease that is responsible for high percentage of culling (reported from 34–62%) in dairy cattle due to infertility and abortion particularly in the second lactation (Herrera et al. Citation2008). It was shown that the incidence of culling due to abortive disorders reached 11% among dairy cattle in Mexico (Herrera et al. Citation2008). It is proposed that brucellosis is the main reason of culling for abortion, although there is no available information on its etiology. Moreover, the presence of adequate veterinary services and the use of disinfectants were reported as protective factors against brucellosis in cattle of Jordan (Al-Majali et al. Citation2009). The most important strategy to control or eradicate brucellosis comprises preventive, test and removal programs including sanitation, vaccination as well as whole herd depopulation (Olsen and Stoffregen Citation2005). The current approach for brucellosis control in different ASEAN countries (Indonesia, Malaysia, Philippines, Singapore, Thailand, Brunei, Laos, Myanmar, Cambodia and Vietnam) is ‘Test-and-slaughter’ strategy. Although this approach is expensive for farmers and governments, it represents an effective protocol for eradicating all emerging and re-emerging zoonotic livestock diseases when the disease prevalence is low (not exceeding 2%) (Zamri-Saad and Kamarudin Citation2016). The screening test for identification of infected herd or farm is the RBT, although the complement fixation test (CFT) is often applied as a complementary confirmation test (Coelho et al. Citation2011; Zamri-Saad and Kamarudin Citation2016).

Livestock vaccination is among the effective programs used for the prevention and control of brucellosis. In endemic areas, vaccination is often used to reduce the incidence of infection and is of overwhelming importance. Cheap and effective life attenuated vaccines such as Brucella melitensis Rev 1 (Rev1), for sheep and goat, and Brucella abortus strain 19 (S19) and B. abortus strain RB51 (RB51) for cattle have been applied successfully in different countries (Ficht et al. Citation2009; Xie et al. Citation2018). However, vaccination alone is not sufficient for the eradication of brucellosis in livestock and should be complemented by a strict test and stamping out the program to completely eliminate the disease. The impact of vaccination on serological screen tests for brucellosis should also be taken into consideration for some vaccines such as RB51. The interpretation of false positive serological results among RB51 vaccinated cattle in endemic zones is still challenging as it is not always clear whether detected antibodies are resulting from pathogenic Brucella infections or passive exposure to Brucella antigens (Herrera et al. Citation2008).

A study, quantifying the production of milk in a dairy cattle population over a 6-year control program for brucellosis in Mexico, revealed that a close association exists between the increase in milk production and the application of a brucellosis control program (Herrera et al. Citation2008). In parallel, an increase in yearly calving was observed due to a significant decrease of abortions. Furthermore, there were lower retained placentas with healthier cows that improve the productivity of the dairy cattle. Another investigation also reported that there were no milk losses due to brucellosis in dairy Holstein herds vaccinated with both RB51 and S19 strains (Mellado et al. Citation2014). In vaccinated herds, it is suggested to use supplemental tests like radial immunodiffusion, beside conventional card and Rivanol tests, in order to maintain the accuracy of diagnostic serological tests (Mellado et al. Citation2014). Furthermore, the cattle vaccination strategy should be reevaluated in Brucella-endemic settings where mixed cattle flocks and small ruminant predominate (Beauvais et al. Citation2016). However, for the control of the spread of brucellosis infection to other localities, it is important to control the movement of animals, particularly for livestock kept under husbandry mixed system including animals of different sex, ages, pregnant and aborted population. In this context, the detection and elimination of the reservoirs, vaccination of young heifers, and regular surveillance tests to identify infected animal herds should be done to prevent the spread of the disease (Rolfe and Sykes Citation1987; Ragan and Animal and Plant Health Inspection Service Citation2002; Ocholi et al. Citation2005).

10. Failure of control of Brucella spp. infection in a dairy herd

The prevalence study on vaccinated herds is required to obtain a comprehensive understanding of the Brucella spp. circulating among livestock population (Azzam et al. Citation2009; Lindahl-Rajala et al. Citation2017). Isolation of a field strain of B. abortus biovar 1 from dairy cattle vaccinated with the RB51 strain showed a failure of the vaccination that could led to the re-emergence of brucellosis (Wareth et al. Citation2016; Alamian et al. Citation2020). Moreover, brucellosis control may be difficult to achieve in some developing countries without securing necessary resources and financial support (Sulima and Venkataraman Citation2010). Another study revealed that failure in the control of Brucella infections could be due to the presence of infected rats and dogs, latently infected heifers, bad hygienic conditions, and the administration of RB51 vaccine that does not confer complete protection against B. melitensis infection (Azzam et al. Citation2009). To guarantee better protection in the vaccination of small ruminants and cattle with B. melitensis Rev1 as well as B. abortus S19, a comprehensive understanding of the circulating field isolates of Brucella spp. among the livestock is necessary (Lindahl-Rajala et al. Citation2017). For this purpose, the use of a panel of screening tests is suggested as the presence of Brucella spp. in seronegative dairy cattle (reported by RBPT), was confirmed in milk samples of dairy cattle by bacteriological test and a PCR technique (Zowghi et al. Citation1990; Islam et al. Citation2018b). Furthermore, the significant role of cats and dogs as potential vector and asymptomatic carriers in the spread of Brucella infections has been reported in dairy farms (Wareth et al. Citation2017). It is now assumed that birds, cats and dogs may infect both livestock and humans and contaminate the environment (Wareth et al. Citation2017). Thus, control programs and the surveillance of brucellosis need to include brucellosis control strategies for bird, dogs, and cats which could be in close contact with dairy cattle. Also, it is important to emphasize that dairy farms using artificial insemination or natural breeding with non-certified bulls for brucellosis are subject to higher brucellosis risks (Cárdenas et al. Citation2019). In the absence of highly effective vaccines and because of difficulties in executing a segregation and slaughter policy of infected animals in endemic countries, control of bovine brucellosis remains a real challenge in many regions (Deka et al. Citation2018).

11. Implementing ‘One Health’ as an integrated approach to brucellosis control in endemic areas

Beside the extensive control programs from veterinary organization, it is thought that brucellosis remains a considerable issue amongst rural and small-scale livestock farmers in the world (Lindahl et al. Citation2014; Montiel et al. Citation2015). Because of the persistence of the pathogen in multiple host species, it remains widespread and neglected in different areas despite significant improvements in technology, management, and diagnostic methods over the last decades (Plumb et al. Citation2013). Therefore, there is a need for critical consideration on the pathogenesis, diagnosis and epidemiology of Brucella to develop management and prevention of brucellosis at local, national, regional and global levels (Plumb et al. Citation2013). It has been suggested that the core competences of an ‘One Health’ approach for brucellosis could be significantly grouped according to ecological, medical, policy and socioeconomic factors (Mazet et al. Citation2009). ‘One Health’ approach highlights education, science, and management factors to evaluate brucellosis by examining issues. Although, ecological parameters are not supposed to play an important role in the persistence of Brucella infection, whereas environmental drivers such as the seasonal variations, animal group size, behavior and host density may influence the transmission trends of brucellosis (Schumaker Citation2013; Dadar et al. Citation2020b). Determining the risks of Brucella spp. transmission may be deeply complicated because they are impacted by different factors such as livestock and wildlife population sizes, location, disease prevalence in wildlife, the susceptibility of livestock, and seasonal frequency of spatiotemporal interactions (Plumb et al. Citation2013; Schumaker Citation2013). Besides, reliable data on Brucella transmission and epidemiology dynamics in different systems, modification of brucellosis prevalence under different control options, economic evaluation of brucellosis on public health and livestock, different control strategies for improvement economic benefits in the animal and human populations could help to the cost assessment of brucellosis in livestock (McDermott et al. Citation2013).

Therefore, international standards to balance reporting, testing, vaccines, as well as control and prevention measures for protecting animal and human health, is an important factor in acceptable and transparent brucellosis management processes. However, specific multidisciplinary ‘One Health’ actions could provide further value regarding conventional or one-disciplinary health activities (Buttigieg et al. Citation2018). ‘One Health’ methods may improve decisions on resource distribution by systemic organization, collaboration, transdisciplinary communication and leadership clarity, as well as essential co-ordination on eradication program of brucellosis after several failed attempts (Mazet et al. Citation2009; Godfroid et al. Citation2013; Buttigieg et al. Citation2018).

12. Conclusions

Brucellosis is considered as one of the most important and widespread zoonotic diseases worldwide. Milk production shows a permanent increase due to the increasing demand for milk and growing population. However, the farmers’ knowledge about the zoonotic preventive practices is still limited. This review aimed at defining how brucellosis control programs could improve dairy production, in terms both of quality and of quantity.

The critical role that can play the implementation of appropriate regulatory practices to control the transmission of the disease and to reduce multiple risks factors associated with brucellosis in dairy farms has been described in detail. Considering the potential public health implication and important economic losses associated with this widespread zoonotic diseases, strict preventive programs should be performed to protect the cattle population from Brucella infections. According to our investigations, multiple factors influence the epidemiology of brucellosis among dairy herds, including management and trade systems, climatic conditions, and agro-ecological zones. All potential risk factors need to be carefully identified and their individual and combined impacts on milk production evaluated in order to design adequate preventive strategies and control programs to improve milk production process in endemic regions. Furthermore, governmental bodies such as veterinary organization and public health authorities should collaborate to manage brucellosis in dairy farms and to reduce the risk of human exposure. In addition, vaccine-based control programs including calf, sheep and goat vaccination appeared to be crucial in endemic areas.

An ‘One Health’ strategy including the development of veterinary capacities/services and the expansion of health education has proved remarkably effective in the control of brucellosis. Furthermore, governmental organisations and regulatory authorities should make efforts to inform farmers about the risks of the replacement of heifers and the introduction of semen from not certified farms. Thus, we recommend control programs within the ‘One Health’ principles to significantly reduce the burden of brucellosis in dairy farms through national vaccination, brucellosis testing and prevention education, while improving public health capacities and international collaborations across endemic regions.

Disclosure statement

No potential conflict of interest was reported by the authors.

Additional information

Funding

This work was supported by the Razi Vaccine and Serum Research Institute (RVSRI); Agricultural Research, Education and Extension Organization (AREEO), Karaj, Iran [grant number 2-18-18-033-950404-3].

References

  • Akhtar R, Chaudhry ZI, Shakoori A, Ahmad M, Aslam A. 2010. Comparative efficacy of conventional diagnostic methods and evaluation of polymerase chain reaction for the diagnosis of bovine brucellosis. Vet World. 3:53–56.
  • Akinseye VO, Adesokan HK, Ogugua AJ, Adedoyin FJ, Otu PI, Kwaghe AV, Kolawole NO, Okoro OJ, Agada CA, Tade AO. 2016. Sero-epidemiological survey and risk factors associated with bovine brucellosis among slaughtered cattle in Nigeria Onderstepoort. J Vet Res. 83:1–7.
  • Alamian S, Dadar M, Wareth G. 2020. Brucella abortus biovar 3 is implicated in an outbreak of abortion in a dairy cattle farm immunized with Brucella abortus Iriba vaccine. Arch Razi Inst. 75:377–384.
  • Alamian S, Dadar M. 2019. Brucella abortus contamination of camel milk in two Iranian regions. Prev Vet Med. 169:104708.
  • Ali Hussein H, Hassan Mohmed R, Mohammed Abdel-Ra A, Mahmoud Abu-Elnaga E, Salah Mohamed R, Abd El-Nasser Hussein A, Wehrend A. 2019. Diagnosis of Brucellosis in recently aborted ewes using serological tests and polymerase chain reaction. J Appl Sci. 19(2):77–81.
  • Ali S, Ali Q, Abatih EN, Ullah N, Muhammad A, Khan I, Akhter S. 2013. Sero-prevalence of Brucella abortus among dairy cattle and buffaloes in Pothohar Plateau, Pakistan. Pak J Zool. 45:1041–1046.
  • Ali S, Ali Q, Melzer F, Khan I, Akhter S, Neubauer H, Jamal SM. 2014. Isolation and identification of bovine Brucella isolates from Pakistan by biochemical tests and PCR. Trop Anim Health Prod. 46(1):73–78.
  • Al-Majali AM, Talafha AQ, Ababneh MM, Ababneh MM. 2009. Seroprevalence and risk factors for bovine brucellosis in Jordan. J Vet Sci. 10(1):61–65.
  • Altun SK, Yiğin A, Gürbilek SE, Gürbüz S, Demirci M, Keskin O, Tel OY. 2016. An enzyme-linked immunosorbent assay for Brucella specific antibody and real-time PCR for detecting Brucella spp. in milk and cheese in Şanlıurfa, Turkey. Pak Vet J. 37:39–42.
  • Amoroso MG, Salzano C, Cioffi B, Napoletano M, Garofalo F, Guarino A, Fusco G. 2011. Validation of a Real-time PCR assay for fast and sensitive quantification of Brucella spp. in water buffalo milk. Food Control. 22(8):1466–1470.
  • Angara T, I Ia AAA, Osman S. 2016. Assessment of the economic losses due to bovine brucellosis in Khartoum State, Sudan. Int J Tech Res Appl. 4:85–90.
  • Araya L, Elzer P, Rowe G, Enright F, Winter A. 1989. Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus. J Immunol. 143(10):3330–3337.
  • Asakura S, Makingi G, Kazwala R, Makita K. 2018. Herd-level risk factors associated with Brucella sero-positivity in cattle, and perception and behaviours on the disease control among agro-pastoralists in Tanzania. Acta Trop. 187:99–107.
  • Asgedom H, Damena D, Duguma R. 2016. Seroprevalence of bovine brucellosis and associated risk factors in and around Alage district, Ethiopia. Springerplus. 5(1):851.
  • Atluri VL, Xavier MN, De Jong MF, Den Hartigh AB, Tsolis RM. 2011. Interactions of the human pathogenic Brucella species with their hosts. Annu Rev Microbiol. 65:523–541.
  • Aulakh H, Patil P, Sharma S, Kumar H, Mahajan V, Sandhu K. 2008. A study on the epidemiology of bovine brucellosis in Punjab (India) using milk-ELISA. Acta Vet Brno. 77(3):393–399.
  • Avila-Granados LM, Garcia-Gonzalez DG, Zambrano-Varon JL, Arenas-Gamboa AM. 2019. Brucellosis in Colombia: current status and challenges in the control of an endemic disease. Front Vet Sci. 6(321). https://doi.org/https://doi.org/10.3389/fvets.2019.00321
  • Awah-Ndukum J, Mouiche M, Bayang H, Ngwa VN, Assana E, Feussom K, Manchang T, Zoli P. 2018. Seroprevalence and associated risk factors of brucellosis among indigenous cattle in the Adamawa and north regions of Cameroon. Vet Med Int. 2018:3468596.
  • Azzam R, El-Gamal A, Elsheemy M. 2009. Failure of control of Brucella melitensis infection in a dairy herd Assiut. Vet. Med. J. 55:274–285.
  • Bale J, Nuru S, Addo P, Adeyinka I. 2003. Bacteriological investigation of sheep and goats milk for brucellosis in government farms in Northern Nigeria. Niger J Anim Prod. 30(1):107–116.
  • Bamaiyi PH. 2015. The economic impact attributable to brucellosis among goat farms in Peninsula Malaysia and cost benefit analysis. Res Opin Anim Vet Sci. 5:57–64.
  • Bano Y, Lone S. 2015. Brucellosis: an economically important infection. J Med Microbiol Diagn. 4 (4):208. https://doi.org/https://doi.org/10.4172/2161-0703.1000208
  • Barrionuevo P, Giambartolomei GH. 2019. Inhibition of antigen presentation by Brucella: many more than many ways. Microbes Infect. 21(3–4):136–142.
  • Bazrgari N, Garosi GA, Dadar M. 2020. Genetic diversity and phylogenetic relationships of Iranian clinical isolates of Brucella melitensis based on RNA Polymerase Beta Subunit (rpoB) Polymorphism. Iran J Med Microbiol. 14(5):425–431.
  • Beauvais W, Musallam I, Guitian J. 2016. Vaccination control programs for multiple livestock host species: an age-stratified, seasonal transmission model for brucellosis control in endemic settings. Parasit Vectors. 9:55.
  • Bittner A. 2004. An overview and the economic impacts associated with mandatory brucellosis testing in Wyoming cattle. Department of Administration and Information, Economic Analysis Division. http://eadiv.state.wy.us.
  • Blasco JM, Molina-Flores B. 2011. Control and eradication of Brucella melitensis infection in sheep and goats. Vet Clin North Am Food Anim Pract. 27(1):95–104.
  • Bounaadja L, Albert D, Chénais B, Hénault S, Zygmunt MS, Poliak S, Garin-Bastuji B. 2009. Real-time PCR for identification of Brucella spp.: a comparative study of IS711, bcsp31 and per target genes. Vet Microbiol. 137(1–2):156–164.
  • Bricker BJ, Halling SM. 1995. Enhancement of the Brucella AMOS PCR assay for differentiation of Brucella abortus vaccine strains S19 and RB51. J Clin Microbiol. 33(6):1640–1642.
  • Brisibe F, Nawathe D, Bot C. 1996. Sheep and goat brucellosis in Borno and Yobe States of arid northeastern. Niger Small Ruminant Res. 20(1):83–88.
  • Brucellosis OIE. 2019. Manual of diagnostic tests and vaccines for terrestrial animals 2019. Paris, France: OIE World Health Organization for Animal Health. p. 355–398.
  • Bundle D, Cherwonogrodzky J, Gidney M, Meikle P, Perry M, Peters T. 1989. Definition of Brucella A and M epitopes by monoclonal typing reagents and synthetic oligosaccharides. Infect Immun. 57(9):2829–2836.
  • Buttigieg SC, Savic S, Cauchi D, Lautier E, Canali M, Aragrande M. 2018. Brucellosis control in Malta and Serbia: a One Health evaluation. Front Vet Sci. 5:147.
  • Buzgan T, Karahocagil MK, Irmak H, Baran AI, Karsen H, Evirgen O, Akdeniz H. 2010. Clinical manifestations and complications in 1028 cases of brucellosis: a retrospective evaluation and review of the literature. Int J Infect Dis. 14(6):e469–e478.
  • Carbonero A, Guzmán L, García-Bocanegra I, Borge C, Adaszek L, Arenas A, Saa L. 2018. Seroprevalence and risk factors associated with Brucella seropositivity in dairy and mixed cattle herds from Ecuador. Trop Anim Health Prod. 50(1):197–203.
  • Cárdenas L, Awada L, Tizzani P, Cáceres P, Casal J. 2019. Characterization and evolution of countries affected by bovine brucellosis (1996–2014). Transbound Emerg Dis. 66(3):1280–1290.
  • Casabuono AC, Czibener C, Del Giudice MG, Valguarnera E, Ugalde JE, Couto AS. 2017. New features in the lipid A structure of Brucella suis and Brucella abortus lipopolysaccharide. J Am Soc Mass Spectrom. 28(12):2716–2723.
  • Chisi SL, Marageni Y, Naidoo P, Zulu G, Akol GW, Van Heerden H. 2017. An evaluation of serological tests in the diagnosis of bovine brucellosis in naturally infected cattle in KwaZulu-Natal province in South Africa. J S Afr Vet Assoc. 88:1–7.
  • Christopher S, Umapathy B, Ravikumar K. 2010. Brucellosis: review on the recent trends in pathogenicity and laboratory diagnosis. J Lab Physicians. 2(2):55–60.
  • Coelho A, Pinto M, Coelho A. 2011. Cost-benefit analysis of sheep and goat brucellosis vaccination with Rev. 1 in the north of Portugal from 2000 to 2005. Arq Bras Med Vet Zootec. 63(1):1–5.
  • Copin R, De Baetselier P, Carlier Y, Letesson J-J, Muraille E. 2007. MyD88-dependent activation of B220-CD11b + LY-6C + dendritic cells during Brucella melitensis infection. J Immunol. 178(8):5182–5191.
  • Cvetnić Ž, Đuras M, Gomerčić T, Reil I, Zdelar-Tuk M, Duvnjak S, Špičić S. 2016. The prevalence of Brucellosis in marine mammals with a special review to Croatia. Veterinarska Stanica: Znanstveno-Stručni Veterinarski Časopis. 47:229.
  • Dadar M, Alamian S, Behrozikhah AM, Yazdani F, Kalantari A, Etemadi A, Whatmore AM. 2019a. Molecular identification of Brucella species and biovars associated with animal and human infection in Iran. Vet Res Forum. 4:315–320.
  • Dadar M, Fakhri Y, Shahali Y, Khaneghah AM. 2020a. Contamination of milk and dairy products by Brucella species: a global systematic review and meta-analysis. Food Res Int. 128:108775.
  • Dadar M, Shahali Y, Fakhri Y. 2020b. A primary investigation of the relation between the incidence of brucellosis and climatic factors in Iran. Microb Pathog. 139:103858.
  • Dadar M, Shahali Y, Whatmore AM. 2019b. Human brucellosis caused by raw dairy products: a review on the occurrence, major risk factors and prevention. Int J Food Microbiol. 292:39–47.
  • de Jong MF, Starr T, Winter MG, den Hartigh AB, Child R, Knodler LA, van Dijl JM, Celli J, Tsolis RM. 2013. Sensing of bacterial type IV secretion via the unfolded protein response. MBio. 4(1):e00418–e00412.
  • Deka RP, Magnusson U, Grace D, Lindahl J. 2018. Bovine brucellosis: prevalence, risk factors, economic cost and control options with particular reference to India-a review. Infect Ecol Epidemiology. 8(1):1556548.
  • Del Giudice MG, Ugalde JE, Czibener C. 2013. A lysozyme-like protein in Brucella abortus is involved in the early stages of intracellular replication. Infect Immun. 81(3):956–964.
  • Detilleux PG, Deyoe BL, Cheville NF. 1990. Penetration and intracellular growth of Brucella abortus in nonphagocytic cells in vitro. Infect Immun. 58(7):2320–2328.
  • El-Amin EO, George L, Kutty NK, Sharma PP, Choithramani RS, Jhaveri VP, Salil P, Bedair SM. 2001. Brucellosis in children of Dhofar Region, Oman. Saudi Med J. 22(7):610–615.
  • El-Wahab EWA, Hegazy Y, Wael F, Mikeal A, Kapaby AF, Abdelfatah M, Bruce M, Eltholth MM. 2019. Knowledge, attitudes and practices (KAPs) and risk factors of brucellosis at the human-animal interface in the Nile Delta, Egypt. BioRxiv:607655. https://doi.org/https://doi.org/10.1101/607655
  • Fernandes DM, Baldwin CL. 1995. Interleukin-10 downregulates protective immunity to Brucella abortus. Infect Immun. 63(3):1130–1133.
  • Ficht TA, Kahl-McDonagh MM, Arenas-Gamboa AM, Rice-Ficht AC. 2009. Brucellosis: the case for live, attenuated vaccines. Vaccine. 27:D40–D43.
  • Fontana C, Conde-Álvarez R, Ståhle J, Holst O, Iriarte M, Zhao Y, Arce-Gorvel V, Hanniffy S, Gorvel J-P, Moriyón I, et al. 2016. Structural studies of lipopolysaccharide-defective mutants from Brucella melitensis identify a core oligosaccharide critical in virulence. J Biol Chem. 291(14):7727–7741.
  • Franc K, Krecek R, Häsler B, Arenas-Gamboa A. 2018. Brucellosis remains a neglected disease in the developing world: a call for interdisciplinary action. BMC Public Health. 18(1):125.
  • Geresu MA, Ameni G, Tuli G, Arenas A, Kassa GM. 2016. Seropositivity and risk factors for Brucella in dairy cows in Asella and Bishoftu towns, Oromia Regional State. Ethiopia. Afr J Microbiol Res. 10:203–213.
  • Głowacka P, Żakowska D, Naylor K, Niemcewicz M, Bielawska-Drózd A. 2018. Brucella - Virulence Factors, Pathogenesis and Treatment. Pol J Microbiol. 67(2):151–161.
  • Godfroid J, Al Dahouk S, Pappas G, Roth F, Matope G, Muma J, Marcotty T, Pfeiffer D, Skjerve E. 2013. A “One Health” surveillance and control of brucellosis in developing countries: moving away from improvisation. Comp Immunol Microbiol Infect Dis. 36(3):241–248.
  • Godfroid J, Nielsen K, Saegerman C. 2010. Diagnosis of brucellosis in livestock and wildlife. Croat Med J. 51(4):296–305.
  • Gopalakrishnan A, Dimri U, Saminathan M, Yatoo M, Priya GB, Gopinath D, Sujatha V, Ajith Y, Suthar A, Lawrence C. 2016. Virulence factors, intracellular survivability and mechanism of evasion from host immune response by Brucella: an overview. J Anim Plant Sci. 12:26.
  • Gulbaz G, Kamber U. 2016. The detection of Brucella bacteria with PCR and bacteriological method in raw milk and some of the dairy products which are consumed in Kars. BUASVMCN-VM. 73(1):127–132.
  • Gür A, Geyik MF, Dikici B, Nas K, Cevik R, Sarac J, Hosoglu S. 2003. Complications of brucellosis in different age groups: a study of 283 cases in southeastern Anatolia of Turkey Yonsei. Yonsei Med J. 44(1):33–44.
  • Gwida M, Al Dahouk S, Melzer F, Rösler U, Neubauer H, Tomaso H. 2010. Brucellosis - regionally emerging zoonotic disease? Croat Med J. 51(4):289–295.
  • Halliday JE, Allan KJ, Ekwem D, Cleaveland S, Kazwala RR, Crump JA. 2015. One health: endemic zoonoses in the tropics: a public health problem hiding in plain sight. Vet Rec. 176(9):220–225.
  • Hamdy M, Amin A. 2002. Detection of Brucella species in the milk of infected cattle, sheep, goats and camels by PCR. Vet J. 163(3):299–305.
  • Havelaar A, Grace D, Wu F. 2019. Foodborne diseases from dairy products in developing countries: hazards and health implications.
  • Herrera E, Palomares G, Díaz‐Aparicio E. 2008. Milk production increase in a dairy farm under a six-year Brucellosis control program. Ann N Y Acad Sci. 1149:296–299.
  • Hoffman T, Rock K, Mugizi DR, Muradrasoli S, Lindahl-Rajala E, Erume J, Magnusson U, Lundkvist Å, Boqvist S. 2016. Molecular detection and characterization of Brucella species in raw informally marketed milk from Uganda. Infect Ecol Epidemiol. 6:32442.
  • Hou H, Liu X, Peng Q. 2019. The advances in brucellosis vaccines. Vaccine. 37(30):3981–3988.
  • Hull NC, Schumaker BA. 2018. Comparisons of brucellosis between human and veterinary medicine. Infect Ecol Epidemiol. 8(1):1500846.
  • Islam A, Hague M, Rahman A, Rahman M, Rahman A, Haque F. 1983. Economic losses due to brucellosis among cattle in Bangladesh. Bangladesh Vet J. 17(4):57–62.
  • Islam M, Filia G, Gupta M. 2018a. Seroprevalence of brucellosis in buffaloes by indirect enzyme linked immunesorbent assay in Punjab, India. Int J Livest Res. 8(5):244–250.
  • Islam MS, Garofolo G, Sacchini L, Dainty AC, Khatun MM, Saha S, Islam MA. 2019. First isolation, identification and genetic characterization of Brucella abortus biovar 3 from dairy cattle in Bangladesh. Vet Med Sci. 5(4):556–562.
  • Islam MS, Islam MA, Khatun MM, Saha S, Basir MS, Hasan M-M. 2018b. Molecular detection of Brucella spp. from milk of seronegative cows from some selected area in Bangladesh. J Pathog. 2018(2018):9378976.
  • Jayarao BM, Pillai S, Sawant A, Wolfgang D, Hegde N. 2004. Guidelines for monitoring bulk tank milk somatic cell and bacterial counts. J Dairy Sci. 87(10):3561–3573.
  • Jezi FM, Razavi S, Mirnejad R, Zamani K. 2019. Immunogenic and protective antigens of Brucella as vaccine candidates. Comp Immunol Microbiol Infect Dis. 65:29–36.
  • Junaidu A, Oboegbulem SI, Salihu M. 2011. Serological survey of Brucella antibodies in breeding herds.
  • Kaden R, Ferrari S, Jinnerot T, Lindberg M, Wahab T, Lavander M. 2018. Brucella abortus: determination of survival times and evaluation of methods for detection in several matrices. BMC Infect Dis. 18(1):1–6.
  • Kamwine M, Orikiriza P, Taseera K, Iramiot JS, Ojuka P, Ikiriza S, Atwebembeire J, Otieno D, Tweshengyereze S, Mwanga-Amumpaire J, et al. 2017. Prevalence of antibodies to Brucella species in commercial raw bovine milk in Southwestern Uganda. BMC Res Notes. 10(1):215.
  • Karthik K, Rathore R, Thomas P, Elamurugan A, Arun T, Dhama K. 2014. Serological and molecular detection of Brucella abortus from cattle by RBPT, STAT and PCR, and sample suitability of whole blood for PCR. Asian J Anim Vet Adv. 9(4):262–269.
  • Kaynak-Onurdag F, Okten S, Sen B. 2016. Screening Brucella spp. in bovine raw milk by real-time quantitative PCR and conventional methods in a pilot region of vaccination, Edirne, Turkey. J Dairy Sci. 99(5):3351–3357.
  • Keid L, Soares R, Vieira N, Megid J, Salgado V, Vasconcellos S, Da Costa M, Gregori F, Richtzenhain L. 2007. Diagnosis of canine brucellosis: comparison between serological and microbiological tests and a PCR based on primers to 16S-23S rDNA interspacer. Vet Res Commun. 31(8):951–965.
  • Kiros A, Asgedom H, Abdi RD. 2016. A review on bovine Brucellosis: epidemiology, diagnosis and control options ARC. J Anim Vet Sci. 2:3–8.
  • Ko J, Splitter GA. 2003. Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans. Clin Microbiol Rev. 16(1):65–78.
  • Kolo FB, Adesiyun AA, Fasina FO, Katsande CT, Dogonyaro BB, Potts A, Matle I, Gelaw AK, Van Heerden H. 2019. Seroprevalence and characterization of Brucella species in cattle slaughtered at Gauteng abattoirs, South Africa. Vet Med Sci. 5(4):545–555.
  • Kumar A, Rahal A, Gupta V. 2019. Oxidative stress, pathophysiology, and immunity in Brucellosis. In: Oxidative stress in microbial diseases. Springer.Singapore, p. 365–378.
  • Langoni H, Ichihara SM, Silva AVd, Pardo RB, Tonin FB, Mendonça LJP, Machado JAD. 2000. Isolation of Brucella spp from milk of brucellosis positive cows in São Paulo and Minas Gerais states. Braz J Vet Res Anim Sci. 37:305–307.
  • Lapaque N, Moriyon I, Moreno E, Gorvel J-P. 2005. Brucella lipopolysaccharide acts as a virulence factor. Curr Opin Microbiol. 8(1):60–66.
  • Leal-Klevezas DS, Martínez-Vázquez IO, Lopez-Merino A, Martínez-Soriano JP. 1995. Single-step PCR for detection of Brucella spp. from blood and milk of infected animals. J Clin Microbiol. 33(12):3087–3090.
  • Leclercq SO, Cloeckaert A, Zygmunt MS. 2020. Taxonomic organization of the family Brucellaceae based on a phylogenomic approach. Front Microbiol. 10:3083. https://doi.org/https://doi.org/10.3389/fmicb.2019.03083
  • Lee JJ, Kim JH, Kim DG, Kim DH, Simborio HL, Min WG, Rhee MH, Lim JH, Chang HH, Kim S. 2014. Characterization of betaine aldehyde dehydrogenase (BetB) as an essential virulence factor of Brucella abortus. Vet Microbiol. 168(1):131–140.
  • Lemos TS, Cequinel JC, Costa TP, Navarro AB, Sprada A, Shibata FK, Gondolfo R, Tuon FF. 2018. Outbreak of human brucellosis in Southern Brazil and historical review of data from 2009 to 2018. PLoS Negl Trop Dis. 12(9):e0006770.
  • Lim JJ, Kim DH, Lee JJ, Kim DG, Min W, Lee HJ, Rhee MH, Kim S. 2012. Protective effects of recombinant Brucella abortus Omp28 against infection with a virulent strain of Brucella abortus 544 in mice. J Vet Sci. 13(3):287–292.
  • Lindahl E, Sattorov N, Boqvist S, Sattori I, Magnusson U. 2014. Seropositivity and risk factors for Brucella in dairy cows in urban and peri-urban small-scale farming in Tajikistan. Trop Anim Health Prod. 46(3):563–569.
  • Lindahl JF, Gill JPS, Hazarika RA, Fairoze NM, Bedi JS, Dohoo I, Chauhan AS, Grace D, Kakkar M. 2019. Risk factors for Brucella seroprevalence in peri-urban dairy farms in five Indian Cities. Trop Med Int Health. 4:70.
  • Lindahl-Rajala E, Hoffman T, Fretin D, Godfroid J, Sattorov N, Boqvist S, Lundkvist Å, Magnusson U. 2017. Detection and characterization of Brucella spp. in bovine milk in small-scale urban and peri-urban farming in Tajikistan. PLoS Negl Trop Dis. 11(3):e0005367.
  • López-Goñi I, García-Yoldi D, Marín CM, de Miguel MJ, Muñoz PM, Blasco JM, Jacques I, Grayon M, Cloeckaert A, Ferreira AC, et al. 2008. Evaluation of a multiplex PCR assay (Bruce-ladder) for molecular typing of all Brucella species, including the vaccine strains. J Clin Microbiol. 46(10):3484–3487.
  • Mableson HE, Okello A, Picozzi K, Welburn SC. 2014. Neglected zoonotic diseases-the long and winding road to advocacy. PLoS Negl Trop Dis. 8(6):e2800.
  • Machavarapu M, Poonati R, Mallepaddi PC, Gundlamadugu V, Raghavendra S, Polavarapu KKB, Polavarapu R. 2019. Endemic brucellosis in Indian animal and human populations: a billion dollar issue. J Curr Trends Biotechnol Pharm. 13:112–123.
  • Mailles A, Garin-Bastuji B, Lavigne JP, Jay M, Sotto A, Maurin M, Pelloux I, O'Callaghan D, Mick V, Vaillant V, et al. 2016. Human brucellosis in France in the 21st century: results from national surveillance 2004–2013. Med Mal Infect. 46(8):411–418.
  • Manchester RC. 1942. The clinical manifestations and diagnosis of chronic brucellosis. Ann Intern Med. 16:950–965.
  • Mancilla M. 2016. Smooth to rough dissociation in Brucella: the missing link to virulence. Front Cell Infect Microbiol. 5:98.
  • Mangtani P, Berry I, Beauvais W, Holt HR, Kulashri A, Bharti S, Sagar V, Nguipdop-Djomo P, Bedi J, Kaur M. 2019. The prevalence and risk factors for human Brucella species infection in a cross-sectional survey of a rural population in Punjab, India. Trans R Soc Trop Med Hyg. 114(4):255–263.
  • Mantur BG, Amarnath SK. 2008. Brucellosis in India - a review. J Biosci. 33(4):539–547.
  • Martín-Martín AI, Sancho P, de Miguel MJ, Fernández-Lago L, Vizcaíno N. 2012. Quorum-sensing and BvrR/BvrS regulation, the type IV secretion system, cyclic glucans, and BacA in the virulence of Brucella ovis: similarities to and differences from smooth brucellae. Infect Immun. 80(5):1783–1793.
  • Martirosyan A, Pérez-Gutierrez C, Banchereau R, Dutartre H, Lecine P, Dullaers M, Mello M, Pinto Salcedo S, Muller A, Leserman L, et al. 2012. Brucella β 1, 2 cyclic glucan is an activator of human and mouse dendritic cells. PLoS Pathog. 8(11):e1002983.
  • Matope G, Bhebhe E, Muma J, Lund A, Skjerve E. 2011a. Risk factors for Brucella spp. infection in smallholder household herds. Epidemiol Infect. 139(1):157–164.
  • Matope G, Bhebhe E, Muma JB, Oloya J, Madekurozwa RL, Lund A, Skjerve E. 2011b. Seroprevalence of brucellosis and its associated risk factors in cattle from smallholder dairy farms in Zimbabwe. Trop Anim Health Prod. 43(5):975–982.
  • Mazet JA, Clifford DL, Coppolillo PB, Deolalikar AB, Erickson JD, Kazwala RR. 2009. A “one health” approach to address emerging zoonoses: the HALI project in Tanzania. PLoS Med. 6(12):e1000190.
  • McDermott J, Grace D, Zinsstag J. 2013. Economics of brucellosis impact and control in low-income countries. Rev Sci Tech. 32(1):249–261.
  • Meador V, Deyoe B, Cheville N. 1989. Pathogenesis of Brucella abortus infection of the mammary gland and supramammary lymph node of the goat. Vet Pathol. 26(5):357–368.
  • Mellado M, Garcia AM, Arellano-Reynoso B, Diaz-Aparicio E, Garcia JE. 2014. Milk yield and reproductive performance of brucellosis-vaccinated but seropositive Holstein cows. Trop Anim Health Prod. 46(2):391–397.
  • Minas A, Minas M, Stournara A, Tselepidis S. 2004. The “effects” of Rev-1 vaccination of sheep and goats on human brucellosis in Greece. Prev Vet Med. 64(1):41–47.
  • Mirabella A, Terwagne M, Zygmunt M, Cloeckaert A, De Bolle X, Letesson J. 2013. Brucella melitensis MucR, an orthologue of Sinorhizobium meliloti MucR, is involved in resistance to oxidative, detergent, and saline stresses and cell envelope modifications. J Bacteriol. 195(3):453–465.
  • Montiel DO, Bruce M, Frankena K, Udo H, van der Zijpp A, Rushton J. 2015. Financial analysis of brucellosis control for small-scale goat farming in the Bajío region, Mexico. Prev Vet Med. 118(4):247–259.
  • Moosazadeh M, Abedi G, Kheradmand M, Safiri S, Nikaeen R. 2016. Seasonal pattern of brucellosis in Iran: a systematic review and meta-analysis. Iran J Health Sci. 4(1):62–72.
  • Moreno E, Cloeckaert A, Moriyón I. 2002. Brucella evolution and taxonomy. Vet Microbiol. 90(1–4):209–227.
  • Mousa AR, Elhag KM, Khogali M, Marafie AA. 1988. The nature of human brucellosis in Kuwait: study of 379 cases. Rev Infect Dis. 10(1):211–217.
  • Ness JM, Ness JM, Moors AJ, Pugh RS. 2017. Risk assessment of brucellosis for tissues processed and archived at the marine environmental specimen bank. US Department of Commerce, National Institute of Standards and Technology. 1211.The United State of America.
  • Nicoletti P. 1984. The control of brucellosis in tropical and subtropical regions. Prev Vet Med. 2(1–4):193–196.
  • Nielsen K. 2002. Diagnosis of brucellosis by serology. Vet Microbiol. 90(1–4):447–459.
  • Nimri LF. 2003. Diagnosis of recent and relapsed cases of human brucellosis by PCR assay. BMC Infect Dis. 3:5.
  • Ning P, Guo K, Xu L, Xu R, Zhang C, Cheng Y, Cui H, Liu W, Lv Q, Cao W, et al. 2012. Short communication: evaluation of Brucella infection of cows by PCR detection of Brucella DNA in raw milk. J Dairy Sci. 95(9):4863–4867.
  • Ning P, Guo M, Guo K, Xu L, Ren M, Cheng Y, Zhang Y. 2013. Identification and effect decomposition of risk factors for Brucella contamination of raw whole milk in China. PLoS One. 8(7):e68230.
  • Ocholi R, Kwaga J, Ajogi I, Bale J. 2005. Abortion due to Brucella abortus in sheep in Nigeria. Rev Sci Tech. 24(3):973–979.
  • Olsen S, Palmer M. 2014. Advancement of knowledge of Brucella over the past 50 years. Vet Pathol. 51(6):1076–1089.
  • Olsen SC, Stoffregen W. 2005. Essential role of vaccines in brucellosis control and eradication programs for livestock. Expert Rev Vaccines. 4(6):915–928.
  • Omer M, Skjerve E, Woldehiwet Z, Holstad G. 2000. Risk factors for Brucella spp. infection in dairy cattle farms in Asmara, State of Eritrea. Prev Vet Med. 46(4):257–265.
  • Pathak AD, Dubal ZB, Karunakaran M, Doijad SP, Raorane AV, Dhuri RB, Bale MA, Chakurkar EB, Kalorey DR, Kurkure NV, et al. 2016. Apparent seroprevalence, isolation and identification of risk factors for brucellosis among dairy cattle in Goa, India. Comp Immunol Microbiol Infect Dis. 47:1–6.
  • Patra S, Tellapragada C, Vandana K, Mukhopadhyay C. 2019. Diagnostic utility of in-house loop-mediated isothermal amplification and real-time PCR targeting virB gene for direct detection of Brucella melitensis from clinical specimens. J Appl Microbiol. 127(1):230–236.
  • Pérez-Sancho M, García-Seco T, Domínguez L, Álvarez J. 2015. Control of animal brucellosis—the most effective tool to prevent human brucellosis. Updates on Brucellosis. 10(61222). DOI:https://doi.org/10.5772/61222
  • Plumb G, Olsen S, Buttke D. 2013. Brucellosis: 'One Health' challenges and opportunities. Rev Sci Tech. 32(1):271–278.
  • Posadas DM, Ruiz‐Ranwez V, Bonomi HR, Martín FA, Zorreguieta A. 2012. BmaC, a novel autotransporter of Brucella suis, is involved in bacterial adhesion to host cells. Cell Microbiol. 14(6):965–982.
  • Proch V, Singh B, Schemann K, Gill J, Ward M, Dhand N. 2018. Risk factors for occupational Brucella infection in veterinary personnel in India. Transbound Emerg Dis. 65(3):791–798.
  • Ragan VE, Animal and Plant Health Inspection Service. 2002. The animal and plant health inspection service (APHIS) brucellosis eradication program in the United States. Vet Microbiol. 90(1–4):11–18.
  • Renukaradhya G, Isloor S, Rajasekhar M. 2002. Epidemiology, zoonotic aspects, vaccination and control/eradication of brucellosis in India. Vet Microbiol. 90(1–4):183–195.
  • Reta MA, Bereda TW, Alemu AN. 2016. Bacterial contaminations of raw cow's milk consumed at Jigjiga City of Somali Regional State, Eastern Ethiopia. Int J Food Contam. 3(4). DOI https://doi.org/10.1186/s40550-016-0027-5
  • Rivera SA, Ramı́rez MC, Lopetegui IP. 2002. Eradication of bovine brucellosis in the 10th Region de Los Lagos, Chile. Vet Microbiol. 90(1–4):45–53.
  • Rolán HG, Tsolis RM. 2008. Inactivation of the type IV secretion system reduces the Th1 polarization of the immune response to Brucella abortus infection. Infect Immun. 76(7):3207–3213.
  • Rolfe D, Sykes W. 1987. Monitoring of dairy herds for Brucella abortus infection when prevalence is low. Aust Vet J. 64(4):97–100.
  • Ruiz-Ranwez V, Posadas DM, Van der Henst C, Estein SM, Arocena GM, Abdian PL, Martín FA, Sieira R, De Bolle X, Zorreguieta A. 2013. BtaE, an adhesin that belongs to the trimeric autotransporter family, is required for full virulence and defines a specific adhesive pole of Brucella suis. Infect Immun. 81(3):996–1007.
  • Salisu U, Kudi C, Bale J, Babashani M, Kaltungo B, Saidu S, Asambe A, Baba A. 2017. Seroprevalence of Brucella antibodies in camels in Katsina State, Nigeria. Trop Anim Health Prod. 49(5):1041–1046.
  • Samartino LE. 2002. Brucellosis in Argentina. Vet Microbiol. 90(1–4):71–80.
  • Santos RL, Martins TM, Borges ÁM, Paixão TA. 2013. Economic losses due to bovine brucellosis in Brazil. Pesq Vet Bras. 33(6):759–764.
  • Scholz HC, Nöckler K, Göllner C, Bahn P, Vergnaud G, Tomaso H, Al Dahouk S, Kämpfer P, Cloeckaert A, Maquart M, et al. 2010. Brucella inopinata sp. nov., isolated from a breast implant infection. Int J Syst Evol Microbiol. 60(Pt 4):801–808.
  • Scholz HC, Pfeffer M, Witte A, Neubauer H, Al Dahouk S, Wernery U, Tomaso H. 2008. Specific detection and differentiation of Ochrobactrum anthropi, Ochrobactrum intermedium and Brucella spp. by a multi-primer PCR that targets the recA gene. J Med Microbiol. 57(Pt 1):64–71.
  • Schumaker B. 2013. Risks of Brucella abortus spillover in the Greater Yellowstone area. Rev Sci Tech. 32(1):71–77.
  • Seimenis A, Araj G, Moriyón I, Tabbaa D. 2019. Brucellosis prevention and control in the mediterranean & middle east regions _a guidance towards approaching the targets. Lebanese Med J. 67:53.
  • Seleem MN, Boyle SM, Sriranganathan N. 2010. Brucellosis: a re-emerging zoonosis. Vet Microbiol. 140(3–4):392–398.
  • Shehabi A, Shakir K, El-Khateeb M, Qubain H, Fararjeh N, Shamat ARA. 1990. Diagnosis and treatment of 106 cases of human brucellosis. J Infect. 20(1):5–10.
  • Singh B, Dhand NK, Gill J. 2015. Economic losses occurring due to brucellosis in Indian livestock populations. Prev Vet Med. 119(3–4):211–215.
  • Singh BB, Kostoulas P, Gill JP, Dhand NK. 2018. Cost-benefit analysis of intervention policies for prevention and control of brucellosis in India. PLoS Negl Trop Dis. 12(5):e0006488.
  • Smith JA. 2018. Brucella lipopolysaccharide and pathogenicity: the core of the matter. Taylor & Francis, Oxfordshire.
  • Sprague LD, Al-Dahouk S, Neubauer H. 2012. A review on camel brucellosis: a zoonosis sustained by ignorance and indifference. Pathog Glob Health. 106(3):144–149.
  • Sriranganathan N, Seleem MN, Olsen SC, Samartino LE, Whatmore AM, Bricker B, O'Callaghan D, Halling SM, Crasta OR, Wattam AR. 2009. Brucella. In: Genome mapping and genomics in animal-associated microbes. Springer, Berlin. p. 1–64.
  • Sulima M, Venkataraman K. 2010. Economic losses due to Brucella melitensis infection in sheep and goats Tamilnadu. J Vet Anim Sci. 6:191–192.
  • Svetić A, Jian YC, Lu P, Finkelman FD, Gause WC. 1993. Brucella abortus induces a novel cytokine gene expression pattern characterized by elevated IL-10 and IFN-gamma in CD4+ T cells. Int Immunol. 5(8):877–883.
  • Tesfaye G, Tsegaye W, Chanie M, Abinet F. 2011. Seroprevalence and associated risk factors of bovine brucellosis in Addis Ababa dairy farms. Trop Anim Health Prod. 43(5):1001–1005.
  • Tukana A, Gummow B. 2017. Dairy farm demographics and management factors that played a role in the re-emergence of brucellosis on dairy cattle farms in Fiji. Trop Anim Health Prod. 49(6):1171–1178.
  • Vizcaíno N, Cloeckaert A. 2012. Biology and genetics of the Brucella outer membrane Brucella. Mol Microbiol Genom. 133:161.
  • Wahab T, Skarp A, Båverud V, Kaden R. 2017. GIFeGSH: a new genomic island might explain the differences in Brucella virulence. OJAS. 07(02):141–148.
  • Wareth G, Melzer F, Böttcher D, El-Diasty M, El-Beskawy M, Rasheed N, Schmoock G, Roesler U, Sprague LD, Neubauer H. 2016. Molecular typing of isolates obtained from aborted foetuses in Brucella-free Holstein dairy cattle herd after immunisation with Brucella abortus RB51 vaccine in Egypt. Acta Trop. 164:267–271.
  • Wareth G, Melzer F, El‐Diasty M, Schmoock G, Elbauomy E, Abdel‐Hamid N, Sayour A, Neubauer H. 2017. Isolation of Brucella abortus from a dog and a cat confirms their biological role in re-emergence and dissemination of bovine brucellosis on dairy farms. Transbound Emerg Dis. 64(5):e27–e30.
  • Wareth G, Melzer F, Elschner MC, Neubauer H, Roesler U. 2014. Detection of Brucella melitensis in bovine milk and milk products from apparently healthy animals in Egypt by real-time PCR. J Infect Dev Ctries. 8(10):1339-1343.
  • Wareth G, Melzer F, Tomaso H, Roesler U, Neubauer H. 2015. Detection of Brucella abortus DNA in aborted goats and sheep in Egypt by real-time PCR. BMC Res Notes. 8:212.
  • Weiner M, Iwaniak W, Zlotnicka J, Szulowski K. 2010. Diagnosis of bovine brucellosis using traditional serological techniques and fluorescence polarisation assay. Bull Vet Inst Pulawy. 54:485–488.
  • Whatmore AM, Davison N, Cloeckaert A, Al Dahouk S, Zygmunt MS, Brew SD, Perrett LL, Koylass MS, Vergnaud G, Quance C, et al. 2014. Brucella papionis sp. nov., isolated from baboons (Papio spp.). Int J Syst Evol Microbiol. 64(Pt 12):4120–4128.
  • Whatmore AM, Koylass MS, Muchowski J, Edwards-Smallbone J, Gopaul KK, Perrett LL. 2016. Extended multilocus sequence analysis to describe the global population structure of the genus Brucella: phylogeography and relationship to biovars. Front Microbiol. 7(2049). https://doi.org/https://doi.org/10.3389/fmicb.2016.02049.
  • Xavier MN, Winter MG, Spees AM, Nguyen K, Atluri VL, Silva TM, Bäumler AJ, Müller W, Santos RL, Tsolis RM. 2013. CD4+ T cell-derived IL-10 promotes Brucella abortus persistence via modulation of macrophage function. PLoS Pathog. 9(6):e1003454.
  • Xie J, Wang J, Li Z, Wang W, Pang Y, He Y. 2018. Ontology-based meta-analysis of animal and human adverse events associated with licensed brucellosis vaccines. Front Pharmacol. 9(503). https://doi.org/https://doi.org/10.3389/fphar.2018.00503
  • Yin D, Bai Q, Li L, Xu L, Xu K, Li J. 2019. Antigenicity and potential use of a novel brucella multiepitope recombinant protein in the diagnosis of brucellosis. BioRxiv. :786343.  https://doi.org/https://doi.org/10.1101/786343
  • Zamri-Saad M, Kamarudin M. 2016. Control of animal brucellosis: the Malaysian experience. Asian Pac J Trop Med. 9(12):1136–1140.
  • Zhang N, Huang D, Wu W, Liu J, Liang F, Zhou B, Guan P. 2018. Animal brucellosis control or eradication programs worldwide: a systematic review of experiences and lessons learned. Prev Vet Med. 160:105–115.
  • Zowghi E, Ebadi A, Mohseni B. 1990. Isolation of Brucella organisms from the milk of seronegative cows. Rev Sci Tech. 9(4):1175–1178.